• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类癌症中的非整倍体:新工具和新视角。

Aneuploidy in human cancer: new tools and perspectives.

机构信息

Cold Spring Harbor Laboratory School of Biological Sciences, Cold Spring, Harbor, NY 11724, USA.

Yale University School of Medicine, New Haven, CT 06511, USA.

出版信息

Trends Genet. 2023 Dec;39(12):968-980. doi: 10.1016/j.tig.2023.09.002. Epub 2023 Sep 29.

DOI:10.1016/j.tig.2023.09.002
PMID:37778926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10715718/
Abstract

Chromosome copy number imbalances, otherwise known as aneuploidies, are a common but poorly understood feature of cancer. Here, we describe recent advances in both detecting and manipulating aneuploidies that have greatly advanced our ability to study their role in tumorigenesis. In particular, new clustered regularly interspaced short palindromic repeats (CRISPR)-based techniques have been developed that allow the creation of isogenic cell lines with specific chromosomal changes, thereby facilitating experiments in genetically controlled backgrounds to uncover the consequences of aneuploidy. These approaches provide increasing evidence that aneuploidy is a key driver of cancer development and enable the identification of multiple dosage-sensitive genes encoded on aneuploid chromosomes. Consequently, measuring aneuploidy may inform clinical prognosis, while treatment strategies that target aneuploidy could represent a novel method to counter malignant growth.

摘要

染色体拷贝数不平衡,也称为非整倍体,是癌症的一个常见但尚未被充分理解的特征。在这里,我们描述了在检测和操纵非整倍体方面的最新进展,这些进展极大地提高了我们研究其在肿瘤发生中的作用的能力。特别是,新的基于簇状规律间隔的短回文重复序列(CRISPR)的技术已经被开发出来,这些技术允许创建具有特定染色体变化的同基因细胞系,从而在遗传控制背景下进行实验,以揭示非整倍体的后果。这些方法提供了越来越多的证据表明,非整倍体是癌症发展的关键驱动因素,并能够识别在非整倍体染色体上编码的多个剂量敏感基因。因此,测量非整倍体可能有助于临床预后,而针对非整倍体的治疗策略可能代表一种对抗恶性生长的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/9783c911d739/nihms-1930551-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/10b1d4f10aa9/nihms-1930551-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/26dd068271f9/nihms-1930551-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/9783c911d739/nihms-1930551-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/10b1d4f10aa9/nihms-1930551-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/26dd068271f9/nihms-1930551-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/10715718/9783c911d739/nihms-1930551-f0003.jpg

相似文献

1
Aneuploidy in human cancer: new tools and perspectives.人类癌症中的非整倍体:新工具和新视角。
Trends Genet. 2023 Dec;39(12):968-980. doi: 10.1016/j.tig.2023.09.002. Epub 2023 Sep 29.
2
Extensive protein dosage compensation in aneuploid human cancers.非整倍体人类癌症中的广泛蛋白质剂量补偿。
Genome Res. 2022 Jul;32(7):1254-1270. doi: 10.1101/gr.276378.121. Epub 2022 Jun 14.
3
KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres.KaryoCreate:一种基于 CRISPR 的技术,通过靶向人类着丝粒研究染色体特异性非整倍性。
Cell. 2023 Apr 27;186(9):1985-2001.e19. doi: 10.1016/j.cell.2023.03.029. Epub 2023 Apr 18.
4
The consequences of chromosomal aneuploidy on the transcriptome of cancer cells.染色体非整倍性对癌细胞转录组的影响。
Biochim Biophys Acta. 2012 Jul;1819(7):784-93. doi: 10.1016/j.bbagrm.2012.02.020. Epub 2012 Mar 6.
5
Polar body analysis by array comparative genomic hybridization accurately predicts aneuploidies of maternal meiotic origin in cleavage stage embryos of women of advanced maternal age.利用 array comparative genomic hybridization 对极体进行分析可准确预测高龄妇女卵裂期胚胎中母源性减数分裂非整倍体。
Hum Reprod. 2013 May;28(5):1426-34. doi: 10.1093/humrep/det053. Epub 2013 Mar 10.
6
The use of copy number loads to designate mosaicism in blastocyst stage PGT-A cycles: fewer is better.在囊胚期植入前基因检测-非整倍体(PGT-A)周期中使用拷贝数负荷来确定嵌合现象:越少越好。
Hum Reprod. 2023 May 2;38(5):982-991. doi: 10.1093/humrep/dead049.
7
Applications of Genome Editing Technology in Research on Chromosome Aneuploidy Disorders.基因组编辑技术在染色体非整倍体疾病研究中的应用。
Cells. 2020 Jan 17;9(1):239. doi: 10.3390/cells9010239.
8
Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces cerevisiae.酿酒酵母中染色体特异性和非整倍体的全局效应
Genetics. 2016 Apr;202(4):1395-409. doi: 10.1534/genetics.115.185660. Epub 2016 Feb 2.
9
Aneuploidy as a driver of human cancer.非整倍体作为人类癌症的驱动因素。
Nat Genet. 2024 Oct;56(10):2014-2026. doi: 10.1038/s41588-024-01916-2. Epub 2024 Oct 2.
10
Immune evasion in HPV head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.HPV 头颈部癌前病变-癌症转化中的免疫逃逸是由涉及 9p 染色体缺失的非整倍体转换驱动的。
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2022655118.

引用本文的文献

1
Molecular Dynamics of Trogocytosis and Other Contact-Dependent Cell Trafficking Mechanisms in Tumor Pathogenesis.肿瘤发病机制中噬细胞作用及其他接触依赖性细胞转运机制的分子动力学
Cancers (Basel). 2025 Jul 8;17(14):2268. doi: 10.3390/cancers17142268.
2
Depletion of aneuploid cells is shaped by cell-to-cell interactions.非整倍体细胞的损耗受细胞间相互作用的影响。
Cell Genom. 2025 Aug 13;5(8):100894. doi: 10.1016/j.xgen.2025.100894. Epub 2025 Jun 3.
3
Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma.

本文引用的文献

1
Evolving copy number gains promote tumor expansion and bolster mutational diversification.不断进化的拷贝数增益促进肿瘤扩张并增强突变多样化。
Nat Commun. 2024 Mar 6;15(1):2025. doi: 10.1038/s41467-024-46414-5.
2
Oncogene-like addiction to aneuploidy in human cancers.人类癌症中类似癌基因的非整倍体成瘾。
Science. 2023 Aug 25;381(6660):eadg4521. doi: 10.1126/science.adg4521.
3
Cancer aneuploidies are shaped primarily by effects on tumour fitness.癌症非整倍体主要由对肿瘤适应性的影响所决定。
多组学分析在早期低分化肺腺癌中识别出具有独特预后的不同分子亚型。
Mol Cancer. 2025 May 1;24(1):129. doi: 10.1186/s12943-025-02333-7.
4
Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes.耐药前列腺癌细胞的单细胞蛋白质组学表征揭示与形态变化相关的分子特征。
Mol Cell Proteomics. 2025 Apr;24(4):100949. doi: 10.1016/j.mcpro.2025.100949. Epub 2025 Mar 14.
5
Proteogenomic analysis reveals adaptive strategies for alleviating the consequences of aneuploidy in cancer.蛋白质基因组分析揭示了癌症中减轻非整倍体后果的适应性策略。
EMBO J. 2025 Mar;44(6):1829-1865. doi: 10.1038/s44318-025-00372-w. Epub 2025 Feb 10.
6
The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study.纵向腰大肌萎缩在预测非小细胞肺癌患者同步放化疗后度伐鲁单抗治疗维持疗效中的意义:一项回顾性研究
Cancers (Basel). 2024 Aug 30;16(17):3037. doi: 10.3390/cancers16173037.
7
FBXO47 regulates centromere pairing as key component of centromeric SCF E3 ligase in mouse spermatocytes.FBXO47 作为着丝粒 SCF E3 连接酶的关键组成部分,调节着丝粒配对,在小鼠精母细胞中。
Commun Biol. 2024 Sep 7;7(1):1099. doi: 10.1038/s42003-024-06782-6.
8
Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer.AurkA/TPX2 过表达对染色体失衡和癌症的贡献。
Cells. 2024 Aug 22;13(16):1397. doi: 10.3390/cells13161397.
9
Patterns of Aneuploidy and Signaling Consequences in Cancer.癌症中的非整倍体模式和信号后果。
Cancer Res. 2024 Aug 15;84(16):2575-2587. doi: 10.1158/0008-5472.CAN-24-0169.
10
Selection forces underlying aneuploidy patterns in cancer.癌症中非整倍体模式背后的选择压力。
Mol Cell Oncol. 2024 Jun 24;11(1):2369388. doi: 10.1080/23723556.2024.2369388. eCollection 2024.
Nature. 2023 Jul;619(7971):793-800. doi: 10.1038/s41586-023-06266-3. Epub 2023 Jun 28.
4
KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres.KaryoCreate:一种基于 CRISPR 的技术,通过靶向人类着丝粒研究染色体特异性非整倍性。
Cell. 2023 Apr 27;186(9):1985-2001.e19. doi: 10.1016/j.cell.2023.03.029. Epub 2023 Apr 18.
5
Targeted assembly of ectopic kinetochores to induce chromosome-specific segmental aneuploidies.靶向组装异位着丝粒以诱导染色体特异性片段非整倍体。
EMBO J. 2023 May 15;42(10):e111587. doi: 10.15252/embj.2022111587. Epub 2023 Apr 17.
6
The evolution of lung cancer and impact of subclonal selection in TRACERx.肺癌的演变及 TRACERx 中亚克隆选择的影响。
Nature. 2023 Apr;616(7957):525-533. doi: 10.1038/s41586-023-05783-5. Epub 2023 Apr 12.
7
A kinesin-based approach for inducing chromosome-specific mis-segregation in human cells.基于驱动蛋白的方法诱导人细胞中染色体特异性错误分离。
EMBO J. 2023 May 15;42(10):e111559. doi: 10.15252/embj.2022111559. Epub 2023 Apr 11.
8
Adaptation to spindle assembly checkpoint inhibition through the selection of specific aneuploidies.通过选择特定的非整倍体来适应纺锤体组装检验点抑制。
Genes Dev. 2023 Mar 1;37(5-6):171-190. doi: 10.1101/gad.350182.122.
9
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis.MACHETE 鉴定出包含干扰素的染色体 9p21.3 缺失可作为免疫逃避和转移的介质。
Nat Cancer. 2022 Nov;3(11):1367-1385. doi: 10.1038/s43018-022-00443-5. Epub 2022 Nov 7.
10
Extensive protein dosage compensation in aneuploid human cancers.非整倍体人类癌症中的广泛蛋白质剂量补偿。
Genome Res. 2022 Jul;32(7):1254-1270. doi: 10.1101/gr.276378.121. Epub 2022 Jun 14.